Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an ...

As a dog owner, if you notice a lump on your female dog's mammary gland, caution is advised. It could be a mammary tumor, ...

A new study from Texas A&M University suggests that dogs with a common type of brain tumor called meningioma may live longer ...

Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment ...

There are around 100 different subtypes of sarcoma that can be classified into three broad groups: soft tissue sarcoma; primary bone sarcoma; and gastro-intestinal stromal tumours. In a non ...

A soft tissue sarcoma (STS) is a malignant tumor that starts in soft tissue such as muscle, deep skin tissues, cartilage, or fat. It often occurs as a lump in the arm, although it can happen anywhere.

Dangers and risks associated with mast cell tumors: Mast cell tumors can be malignant or benign, so your vet will need to examine your dog. Malignant tumors, called mastocytomas, can be very ...

Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor ...

Ewing sarcoma is an aggressive malignant bone and soft tissue tumor that primarily affects children and young adults. A characteristic feature of the tumor is a spontaneous mutation that results in ...

Credit: Getty Images A liposarcoma is a type of soft tissue sarcoma, which is a rare type of cancer, that begins in fat cells. A lipoma is a noncancerous tumor that develops just beneath the skin.

Telix Pharmaceuticals Limited today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx (89Zr-olaratumab) in patients with advanced, metastatic soft tissue ...

for advanced soft tissue sarcoma (STS) treatment at the Melbourne Theranostic Innovation Centre (MTIC), the company announced on Monday. This trial marks the first-in-human study of olaratumab as ...